| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/29/2006 | WO2006066960A1 Variant tfpi with increased anti-thrombotic activity |
| 06/29/2006 | WO2006066959A1 Fusion proteins and methods for determining protein-protein-interactions in living cells and cell lysates, nucleic acids encoding these fusion proteins, as well as vectors and kits containing these |
| 06/29/2006 | WO2006066925A2 Novel genes involved in gluconeogenesis |
| 06/29/2006 | WO2006066878A1 Prevention of thrombus formation and/or stabilization |
| 06/29/2006 | WO2006066758A1 Mutant of the prob gene from coryneform bacteria |
| 06/29/2006 | WO2006066595A2 Recombinant production of serum albumin |
| 06/29/2006 | WO2006066498A1 The transcription factor gene osnacx from rice and use for improving tolerance of plants to drought and salt thereof |
| 06/29/2006 | WO2006066463A1 Receptor-selective lymphotoxin deviants |
| 06/29/2006 | WO2006066358A1 Vacuole targeting peptide and nucleic acid |
| 06/29/2006 | WO2006066355A1 Chitin-binding peptides |
| 06/29/2006 | WO2006066334A1 Potassium channels in human heart |
| 06/29/2006 | WO2006042558A3 Group 2 mite polypeptide variants |
| 06/29/2006 | WO2006040129A3 Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
| 06/29/2006 | WO2006037421A3 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 06/29/2006 | WO2006036834A3 MODIFIED Fc MOLECULES |
| 06/29/2006 | WO2006027468A3 Hla-dp4 restricted t cd4+ du vih epitopes and the use thereof |
| 06/29/2006 | WO2006025990A3 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 06/29/2006 | WO2006023420A3 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 06/29/2006 | WO2006021599A8 Use of amphiregulin as a protective agent in acute hepatic injury |
| 06/29/2006 | WO2006019804A3 Compositions and methods of purifying myelin-associated glycoprotein (mag) |
| 06/29/2006 | WO2005118823A3 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 06/29/2006 | WO2005118790A3 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins |
| 06/29/2006 | WO2005118782A3 Methods of promoting cardiac cell proliferation |
| 06/29/2006 | WO2005116061A3 Sequences for the synthesis of antibacterial polyketides |
| 06/29/2006 | WO2005110338A3 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 06/29/2006 | WO2005087793A3 Immunostimulatory compositions and uses thereof |
| 06/29/2006 | WO2005084410A3 Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 06/29/2006 | WO2005080417A3 Recombinant viruses with heterologous envelope proteins |
| 06/29/2006 | WO2005062864A3 Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent |
| 06/29/2006 | WO2005019242A8 Recombinant expression of the hag1 antimicrobial peptide: use as fusion partner for the expression of alpha helical antimicrobial peptides |
| 06/29/2006 | WO2005015154A3 Autocatalysis/yeast two-hybrid assay |
| 06/29/2006 | WO2005001092A3 Compositions and methods for diagnosing and treating cancers |
| 06/29/2006 | WO2005001050A3 Transcription factors |
| 06/29/2006 | WO2004093782A3 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 06/29/2006 | WO2004089292A3 Immunomodulatory agents for treatment of inflammatory diseases |
| 06/29/2006 | WO2004066935A3 Sensitive proteasome sensor constructs and methods for their design and use |
| 06/29/2006 | WO2004044125A3 Vesicle-associated proteins |
| 06/29/2006 | WO2004019880A3 Aw755252-interacting proteins and use thereof |
| 06/29/2006 | WO2003093444A3 Transporters and ion channels |
| 06/29/2006 | WO2003091413A3 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 06/29/2006 | US20060143734 For transfecting a plant cell, transgenic plant |
| 06/29/2006 | US20060143730 Controlling gene expression of plastids; encoding acetolactate synthase ; herbide resistance to plants; detction targte genes |
| 06/29/2006 | US20060143728 Maize multidrug resistance-associated protein polynucleotides and methods of use |
| 06/29/2006 | US20060143724 Transgenic mice containing anaphylatoxin C3a gene disruptions |
| 06/29/2006 | US20060143720 Transgenic mice containing chordin gene disruptions |
| 06/29/2006 | US20060142558 Novel proteins and their uses |
| 06/29/2006 | US20060142549 Method of purifying protein |
| 06/29/2006 | US20060142548 Methods of identifying and designing cell surface receptor inhibitors |
| 06/29/2006 | US20060142547 Anktm1, a cold-activated trp-like channel expressed in nociceptive neurons |
| 06/29/2006 | US20060142546 Immunogenic muc1 glycopeptides |
| 06/29/2006 | US20060142222 Novel gene relating to fibrotic conditions |
| 06/29/2006 | US20060142221 Vaccine |
| 06/29/2006 | US20060142220 Protein modification |
| 06/29/2006 | US20060142219 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2006 | US20060142218 Method of controlling telomere length |
| 06/29/2006 | US20060142203 Antiproliferative agents; angiogenese inhibitors; antiinflammatory agents; anticancer agents |
| 06/29/2006 | US20060142200 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
| 06/29/2006 | US20060142199 CD-44 like protein |
| 06/29/2006 | US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 06/29/2006 | US20060142195 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 06/29/2006 | US20060142192 Soluble ZcytoR21, anti-ZcytoR21 antibodies and binding partners and methods of using in inflammation |
| 06/29/2006 | US20060142189 polypeptides derived from the ankyrin binding domain of the L1-cellular adhesion molecules (L1-CAM), used in the treatment of strokes,neurodegenerative disease, spinal cord and brain injuries |
| 06/29/2006 | US20060142188 Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof |
| 06/29/2006 | US20060142185 Use of lupin conglutin for the treatment of type II diabetes |
| 06/29/2006 | US20060141602 Packaging of positive-strand RNA virus replicon particles |
| 06/29/2006 | US20060141597 Valency platform molecules comprising aminooxy groups |
| 06/29/2006 | US20060141581 IL-7 variants with reduced immunogenicity |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141578 effective protein synthesis by regulating the expression of a protein in a host cell; preparing transgenic cells and inducing expression of heterologous sequences; tissue engineering and in vitro translation; efficiency and convenience |
| 06/29/2006 | US20060141577 Selection of host cells expressing protein at high levels |
| 06/29/2006 | US20060141576 Variants of corticotropin releasing hormone receptor type 1 and uses thereof |
| 06/29/2006 | US20060141575 Secreted proteins and nucleic acids encoding them |
| 06/29/2006 | US20060141573 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 06/29/2006 | US20060141572 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| 06/29/2006 | US20060141569 Compositions and methods for the assay of G-protein coupled receptors and their ligands |
| 06/29/2006 | US20060141568 Modification of collagenous materials and medical treatment, diagnosis and monitoring of fibrotic conditions |
| 06/29/2006 | US20060141567 For selective modulation of leukocyte function, which is useful in a variety of inflammatory and autoimmune diseases, or in therapy of infections |
| 06/29/2006 | US20060141565 Novel fibroblast growth factor and uses thereof |
| 06/29/2006 | US20060141564 Nucleic acids encoding duramycin |
| 06/29/2006 | US20060141563 Mutant protein and refolding method |
| 06/29/2006 | US20060141561 Apo-2 ligand/trail variants and uses thereof |
| 06/29/2006 | US20060141560 Estrogen receptor genes and utilization thereof |
| 06/29/2006 | US20060141540 Direct selection of cells by secretion product |
| 06/29/2006 | US20060141535 Hyaluronan receptor for endocytosis |
| 06/29/2006 | US20060141531 Self-assembled relay probe; peptide tag bound to the target material; a fluorescent conjugate, a fluorochrome and a tag binding group; conjugate selectively associates with the first tag; a second peptide tag bound to the target material with a second fluorochrome having a longer wavelength |
| 06/29/2006 | US20060141530 Using arsenic-mediated labeling to permit orthogonal molecule-specific, site-specific labeling of target molecules, such as proteins, with multiple labels; complex of peptide with tag of a cyanine dye having pendant 2,5-dithia-arsacyclopentane groups |
| 06/29/2006 | US20060141525 Use of lectin library for distinguishing glycoproteins or cells, diagnosing serum or cells, or fractionating glycoproteins or cells |
| 06/29/2006 | US20060141522 Screening methods for identifying agonists and antagonists of hereulin -like factor (HLF) activity; diagnostic methods for detecting disorders of the regulation of cell growth and therapeutic methods for treating disorders of the regulation |
| 06/29/2006 | US20060141520 Methods for the treatment of metabolic disorders, including obesity and diabetes |
| 06/29/2006 | US20060141517 Protein having PDZ domain sequence |
| 06/29/2006 | US20060141479 Diagnosis, psoriasis, rheumatoid arthritis, emphysema, asthma, diabetes, autoimmune thyroiditis, inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, different types of dermatitis including allergic dermatitis, contact dermatitis, actinic keratosis, wound healing, cancer |
| 06/29/2006 | US20060141476 Growth arrest homeobox gene |
| 06/29/2006 | US20060141468 Novel notch-like polypeptides |
| 06/29/2006 | US20060141462 Human type II diabetes gene-slit-3 located on chromosome 5q35 |
| 06/29/2006 | US20060141458 Method of identifying genes involved in cell growth regulation |
| 06/29/2006 | US20060141455 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 06/29/2006 | US20060141453 Prokineticin polypeptides, related compositions and methods |
| 06/29/2006 | US20060141451 Guinea pig proteinase-activated receptor 4 and its activating peptide |
| 06/29/2006 | US20060141444 Adherent entities and uses therefor |